Vitamin K3 treatment in Stomach Cancer patients in a public hospital
Phase 2
Recruiting
- Conditions
- Malignant neoplasm of cardiaMalignant neoplasm of the fundus of the stomachMalignant neoplasm of the body of the stomachMalignant neoplasm of the pyloric antrumMalignant neoplasm of the pylorusMalignant neoplasm of stomach with invasive lesion
- Registration Number
- RBR-76j763k
- Lead Sponsor
- Hospital Ophir Loyola
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with locally advanced (T2, T3 or T4) and/or incurable disease; with a performance status between 0 and 2 according to the criteria defined by the Eastern Cooperative Oncology Group or greater than or equal to 60% by the Karnofsky performance status; with adequate organ and bone marrow functions and left ventricular ejection fraction above 50%
Exclusion Criteria
Patients with brain metastases, angina, intestinal obstruction, active gastrointestinal bleeding and an estimated life of less than three months; with clinically significant comorbidities that may interfere with treatment tolerance and efficacy; on warfarin
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method